Speaker's Highlight

• Don Sin University of British Columbia, St. Paul Hospital (Canada)
  Kenneth R. Chapman Toronto General Hospital Research Institute (Canada)
• Parameswaran Nair McMaster University (Canada)
  Carolyn Calfee UCSF (U.S.A.)
• Gregory P. Downey University of Colorado School of Medicine (U.S.A.)
  David A. Schwartz University of Colorado School of Medicine (U.S.A.)
• Neil Schluger Tuberculosis Control Branch, California Department of Public Health (U.S.A.)
  Nick Kim Critical Care & Sleep Medicine, University of California San Diego (U.S.A.)
• Nicola Hananiah Baylor College of Medicine (U.S.A.)
  Jae-Joon Yim Seoul National University College of Medicine (Republic of Korea)
• Koichiro Asano Tokai University School of Medicine (Japan)
  Diahn-Warng Perng Taipei Veterans General Hospital (Taiwan)
• Konstantinos Kostikas University of Ioannina (Greece)
  Karin Klooster University Medical Center Groningen (Kingdom of the Netherlands)

• Pectoralis muscle area as a frailty marker in COPD

  Chronic obstructive pulmonary disease (COPD) is commonly assessed through airflow limitation, symptoms and exacerbation history. Yet lung function alone does not show how well a person can stand, walk, eat, recover from illness or manage daily activities. Muscle loss can reveal a wider decline in physiological reserve before disability becomes obvious.

  The use of pectoralis muscle area as a frailty marker in COPD is gaining attention because chest imaging is already part of care for many patients. A computed tomography (CT) scan performed for emphysema, lung nodules or suspected cancer may contain additional information about skeletal muscle without requiring another test.

  This approach is relevant in Australia, where people with COPD may live far from specialist respiratory services. A patient in regional Queensland, Western Australia or Tasmania might have fewer opportunities for repeated exercise testing, dietetic review or pulmonary rehabilitation. An imaging-based marker could help clinicians identify who needs earlier support.

  Pectoral muscle measurement should not replace clinical assessment. It is best viewed as one component of a broader frailty profile that includes weight change, strength, mobility, nutrition, breathlessness, comorbidities and the person’s ability to cope at home.

  Why frailty matters in COPD

  Frailty describes reduced resilience to stressors such as infection, hospitalisation, surgery or an acute exacerbation. In COPD, it can develop through inactivity, systemic inflammation, poor appetite, hypoxaemia, corticosteroid exposure and the high energy cost of breathing. The result may be weakness, slower recovery and increasing dependence.

  A frail person with moderate spirometric impairment can sometimes fare worse than a fitter person with more severe obstruction. This is why clinicians increasingly consider physical performance and body composition alongside forced expiratory volume in one second (FEV1).

  Frailty also affects treatment decisions. It may influence whether a patient can complete pulmonary rehabilitation, use inhalers correctly, maintain nutrition or return safely home after admission. Recognising it early supports more realistic, individualised care.

  What the pectoralis muscle measurement shows

  The pectoralis major and minor muscles sit across the upper chest and can be measured on selected axial CT images. Researchers commonly assess cross-sectional area or muscle density at a consistent anatomical level, then adjust the result for body size, sex or other patient characteristics.

  A smaller pectoralis muscle area may indicate sarcopenia, reduced physical reserve or chronic muscle wasting. Lower muscle attenuation can also suggest fatty infiltration, which may reflect poorer muscle quality even when total area appears relatively preserved.

  The measurement is attractive because it is opportunistic. No additional radiation is required when a clinically indicated CT scan already exists. However, results depend on scanner settings, slice position, segmentation technique and the reference population used to define low muscle quantity.

  Links with outcomes and disease burden

  Studies in COPD have associated reduced chest muscle area with lower exercise capacity, more severe dyspnoea, frequent exacerbations and increased mortality risk. These relationships make biological sense: weak respiratory and peripheral muscles can increase the work of breathing and reduce the capacity to respond to infection or exertion.

  Pectoralis depletion may also accompany emphysema, low body mass index and reduced fat-free mass. A body mass index within the normal range does not exclude clinically important muscle loss, particularly in older adults or people whose weight is maintained by fat rather than lean tissue.

  The marker should be interpreted as a risk signal rather than a diagnosis. A single measurement cannot distinguish all causes of low muscle bulk, and it should not be used in isolation to predict an individual outcome.

  Making the result clinically useful

  A low pectoralis muscle area should prompt a structured review. Clinicians can check recent weight change, dietary intake, grip strength, gait speed, chair-rise performance, falls, activity levels and medication burden. Screening tools such as the Clinical Frailty Scale or a validated sarcopenia pathway may add practical context.

  Functional measures remain important because they describe what the patient can actually do. Six-minute walk distance, sit-to-stand testing and handgrip strength may reveal limitations that imaging cannot capture. In a busy Australian respiratory clinic, combining a CT-derived marker with a brief functional screen may be more feasible than ordering extensive investigations for every patient.

  The patient’s goals also matter. Someone living independently in Melbourne may prioritise returning to work or public transport use, while an older person in a remote community may focus on shopping, maintaining cultural connections or managing stairs at home.

  Nutrition, rehabilitation and self-management

  Low muscle reserves should lead to practical intervention rather than simply a risk label. Pulmonary rehabilitation can improve exercise tolerance, breathlessness management and confidence. Resistance training is particularly relevant because aerobic activity alone may not restore muscle strength.

  Dietary assessment can identify inadequate protein or energy intake, swallowing difficulties, dental problems and the impact of fatigue on meal preparation. Australian clinicians may need to consider food costs, distance to supermarkets and culturally appropriate eating patterns. Referral to an accredited practising dietitian can be useful when weight loss or suspected sarcopenia is present.

  Smoking cessation remains central, including support for people using nicotine products. Exposure to bushfire smoke and urban air pollution can worsen respiratory symptoms during some Australian summers, so an individual action plan should include advice about indoor air quality and avoiding strenuous outdoor activity during hazardous periods.

  Imaging standards and ethical safeguards

  For pectoralis muscle area to become reliable in routine practice, services need consistent anatomical landmarks, measurement protocols and reporting language. Automated or semi-automated software may improve efficiency, but clinicians must understand its limitations and confirm unexpected results.

  CT findings should be communicated carefully. Describing low muscle area as a possible marker of reduced reserve is more appropriate than presenting it as proof of frailty. Patients should understand how the finding may guide rehabilitation, nutrition or follow-up rather than create unnecessary alarm.

  Data governance also matters. Australian services must handle imaging and health information under applicable privacy obligations, including the Privacy Act 1988 and state or territory requirements. Any research database should use appropriate consent, secure storage and transparent access rules.

  Applying the marker across Australian care settings

  Australian respiratory care is delivered across major hospitals, private practices, community services and telehealth networks. A CT-based frailty signal may help prioritise referrals to pulmonary rehabilitation or geriatric medicine, particularly when specialist appointments are limited in regional areas.

  The approach could be useful before lung cancer surgery, lung volume reduction procedures or prolonged hospital treatment, where nutritional and functional reserve affect recovery. It may also support discharge planning after an exacerbation, alongside medication reconciliation and home safety assessment.

  Implementation should account for the local health system. Medicare-supported services, hospital imaging pathways and state-based pulmonary rehabilitation programs vary, while the Therapeutic Goods Administration regulates medicines and devices rather than muscle assessment itself. Clear referral pathways are needed so that identifying risk leads to action.

  People travelling to an international respiratory congress or arranging clinical visits should review Australian visa information early, particularly when schedules include workshops, committee meetings or presentations on advanced COPD assessment.

  Practical recommendations for clinicians

  • Review pectoralis muscle area only from clinically justified CT imaging; do not order scans solely to measure muscle.
  • Use a consistent slice level, segmentation method and body-size adjustment within each service.
  • Combine imaging with weight history, grip strength, gait or chair-rise testing, symptoms and activities of daily living.
  • Refer patients with suspected frailty to pulmonary rehabilitation, resistance exercise and dietetic assessment when appropriate.
  • Reassess after hospitalisation, exacerbation or substantial weight change rather than relying on one static measurement.
  • Explain the finding as a modifiable risk marker and involve the patient in setting functional goals.
  • Record enough technical detail to make measurements comparable across hospitals and over time.

  Pectoralis muscle area offers a practical window into the physical reserve of people with COPD, especially when chest CT is already available. Its value is greatest when it connects imaging with strength, nutrition, mobility and patient priorities. The key point to remember is that a smaller chest muscle area should trigger a fuller assessment and timely support, not stand alone as a diagnosis of frailty.

  Richard Russell Nuffield Department of Clinical Medicine, University of Oxford (United Kingdom)
• Mona Bafadhel King’s College London (United Kingdom)
  David Jackson Guy’s and St Thomas’ Hospital, King’s College London (United Kingdom)
• James Chalmers University of Dundee (United Kingdom)
  David Price University of Aberdeen (United Kingdom)